Chronix Teams with Hemispherx on Chronic Fatigue MDx | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Chronix Biomedical is working with drug development firm Hemispherx Biopharma on developing a molecular diagnostic test for chronic fatigue syndrome.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.